Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study

Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strategy in clinical routine are scant. We evaluated treatment outcomes of ATV + ABC/3TC in pretreated subjects in the EuroSIDA cohort when started with undetectable plasma HIV-1 viral load (pVL), performin...

Descripción completa

Detalles Bibliográficos
Autores principales: Llibre, Josep M., Cozzi-Lepri, Alessandro, Pedersen, Court, Ristola, Matti, Losso, Marcelo, Mocroft, Amanda, Mitsura, Viktar, Falconer, Karolin, Maltez, Fernando, Beniowski, Marek, Vullo, Vincenzo, Hassoun, Gamal, Kuzovatova, Elena, Szlavik, János, Kuznetsova, Anastasiia, Stellbrink, Hans-Jürgen, Duvivier, Claudine, Edwards, Simon, Laut, Kamilla, Paredes, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059063/
https://www.ncbi.nlm.nih.gov/pubmed/27749561
http://dx.doi.org/10.1097/MD.0000000000005020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059063/
https://www.ncbi.nlm.nih.gov/pubmed/27749561
http://dx.doi.org/10.1097/MD.0000000000005020

Ejemplares similares